71 / 112
69
WFSBP 2015
Wednesday, 17 June 2015
|
Scientific Programme
P-16-013
Tolerability, safety and treatment response of flexibly-dosed
paliperidone palmitate in patients hospitalized for an ex-
acerbation of schizophrenia
Andreas Schreiner, Germany
L. Hargarter, M. Lahaye, P. Cherubin
P-16-015
A role for D-aspartate oxidase in schizophrenia and in
schizophrenia-related symptoms induced by phencycli-
dine in mice
Francesco Errico, Italy
V. D´Argenio, F. Sforazzini, M. Squillace, F. Napolitano,
T. Angrisano, D. Vitucci, A. Di Maio, L. Chiariotti, A. de Bar-
tolomeis, A. Gozzi, A. Usiello
P-16-016
Biomarker profiles decode symptoms of psychosis: Evi-
dence for a new age of biological psychiatry
Stephanie Fryar-Williams, Australia
P-16-017
Characterising language comprehension in schizophrenia
and its relationship with language production problems
Eric Tan, Australia
G. Yelland, S. Rossell
P-16-018
Clinical studies of biomarkers of the indolic hypermethyl-
ation in human perception alterations
Jorge Ciprian Ollivier, Argentina
A. Vitale, E. Romero, M. Vitale, A. Pomilio
P-16-019
D-cell hypothesis of schizophrenia: Link of NSC hypothesis
to dopamine hypothesis
Keiko Ikemoto, Japan
P-16-020
Does cortical thickness act as a mediator between child-
hood sexual trauma and transition to psychosis in young
individuals at ultra-high risk of psychosis?
Eleni Ganella, Australia
M. Rapado-Castro, S. Whittle, A. Thompson, B. Nelson, A.
Lin, C. Pantelis, P. McGorry, A. R. Yung, S. J. Wood, C. F.
Bartholomeusz
P-16-021
Effect of carbonyl stress on cognitive impairment in schi
zophrenia patients
Akiko Kobori, Japan
S. Hatakeyama, M. Arai, Y. Horiuchi, K. Toriumi, M. Miyas-
hita, H. Arai, M. Itokawa
P-16-022
Enhancing cognitive functions in schizophrenia: A rand-
omized controlled yoga trial
Ruben Gur, India
T. Bhatia, S. Mazumdar, J. Wood, F. He, R. Gur, V. Nimgaon-
kar, S. Deshpande
P-16-023
Investigation of the neurobiology of effort valuation impair-
ments in schizophrenia in a virtual environment
George Foussias, Canada
I. Siddiqui, C. Hawco, G. Fervaha, S. Saperia, J. Zawadzki,
K. Zakzanis, A. Wong, O. Agid, G. Remington
P-16-024
Lipid profile in schizophrenia and first-episode psychosis:
About a Tunisian population
Ahmed Mhalla, Tunisia
R. Mensi, A. Messaoud, I. Azizi, W. Douki, F. Najjar, L. Gaha
P-16-025
Long-term improvements in auditory verbal hallucinations:
Clinician vs. patient perspectives
In Won Chung, Republic of Korea
S. S.-Hyun Hwang, S. H. Kim, J. S. Chang, H. Y. Jung, Y. S. Kim
P-16-026
Maternal immune activation at the precise times of preg-
nancy causes social deficits and decreased prefrontal cortex
BDNF levels in rat offspring
Eliza Koros, Germany
H. Rosenbrock
P-16-028
Peripheral blood markers of dopamine level and oxidative
stress in schizophrenia, South India
Mahalaxmi Iyer, India
G. Mohan, A. Meyyazhagan, G. Changrathil, S. Keshavarao,
D. S.N., B. Vellingiri
P-16-029
Frontal brain activation during emotional stroop task in
individuals at risk for schizophrenia and bipolar disorder
using functional near-infrared spectroscopy
Aleksandra Aleksandrowicz, Switzerland
F. Hagenmuller, H. Haker Rössler, K. Heekeren, A. Theodori-
dou, S. Walitza, W. Rössler, W. Kawohl
P-17
Poster Presentation
12:45–14:15
Muses Foyer
Personality Disorders/Violence/Suicide/Forensic Psychiatry
Chair:
Athanasios Douzenis, Greece
Co-Chair: George Kiosterakis, Greece
P-17-001
A French cohort of paraphilic sex offenders: Preliminary
results
Sandrine Lamy, France
V. Olivier, E. Houivet, J. Benichou, H. Delavenne, F. Thibaut